GlassScriptPhysician profile
Michael R Cozzetta
NPI 1043277973
$466.17
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.33 · 2020: $74.90 · 2021: $204 · 2022: $145.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $187.30 | 2020-2021 | |
| Abbvie INC. | $109.99 | 2022 | |
| Maculogix, INC. | $42.00 | 2021 | |
| Biotissue Holdings INC. | $32.90 | 2021-2022 | |
| Carl Zeiss Meditec, INC. | $24.10 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $19.03 | 2022 | |
| Allergan, INC. | $15.02 | 2021 | |
| Abb Con-Cise Optical Group LLC | $12.32 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $12.22 | 2020 | |
| Sun Pharmaceutical Industries INC. | $11.29 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cozzetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.